Dr Rong Liu is a public health researcher with expertise in evidence synthesis, implementation science, and health economic evaluations. Her research spans both non-communicable and infectious diseases, with a focus on generating evidence to inform health policy and practice. Her PhD investigated the efficacy, safety, feasibility, and cost-effectiveness of influenza vaccination among people with cardiovascular diseases in hospital settings.

Dr Liu has broad experience in health technology assessment, policy evaluation, micro-costing of virtual models of care, and epidemiological modelling of antimicrobial resistance testing strategies. Her research integrates epidemiological, implementation, and economic methods to evaluate healthcare interventions and improve population health outcomes.

At the Kirby Institute, Dr Liu’s research focuses on the epidemiology of Hepatitis B and Hepatitis C, particularly among people who inject drugs and individuals in custodial settings. Her work aims to support evidence-based strategies for the prevention, treatment, and elimination of viral hepatitis in priority settings.